Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 24, 2015 8:16 PM ET

Healthcare Equipment and Supplies

Company Overview of Veracyte, Inc.

Company Overview

Veracyte, Inc. operates as a molecular diagnostics company in the United States. It operates in the field of molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patient care. The company offers Afirma Thyroid FNA Analysis solution for use in thyroid cancer diagnosis; cytopathology testing services; and the Afirma Malignancy Classifiers, which comprise the genomic tests for medullary thyroid cancer and BRAF V600E mutation status. It also develops a product to preoperatively identify idiopathic pulmonary fibrosis among patients presenting with a suspected interstitial lung disease; and the P...

7000 Shoreline Court

Suite 250

South San Francisco, CA 94080

United States

Founded in 2006

167 Employees





Key Executives for Veracyte, Inc.

Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Age: 57
Total Annual Compensation: $425.0K
Chief Financial Officer, Principal Accounting Officer and Member of Non-Management Equity Award Committee
Age: 55
Total Annual Compensation: $300.0K
Chief Operating Officer
Age: 46
Total Annual Compensation: $341.2K
Compensation as of Fiscal Year 2014.

Veracyte, Inc. Key Developments

Veracyte, Inc. Appoints Tina S. Nova as Director and Chairman of the Regulatory and Compliance Committee

Effective November 12, 2015, the Board of Directors of Veracyte, Inc. elected Tina S. Nova, Ph.D. to the company's Board of Directors. In addition to serving on the Board of Directors, Dr. Nova will also serve as Chairman of the Regulatory and Compliance Committee of the Board of Directors. Dr. Nova, age 62, is a life sciences industry veteran with extensive experience building and leading novel genomics-based businesses. Since October 2015, she has served as president and chief executive officer of Molecular Stethoscope, Inc., a molecular diagnostics company.

Veracyte, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Reiterates Revenue Guidance for the Year 2015

Veracyte, Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, revenue was $12.3 million, an increase of 25%, compared to $9.8 million for the third quarter of 2014. Net loss for the third quarter of 2015 was $8.9 million, or $0.32 per common share, versus a net loss of $7.9 million, or $0.37 per common share, for the same period in 2014. Loss from operations was $8,888,000 compared to $7,811,000 a year ago. For the nine months, revenue was $35,461,000, compared to $25,991,000 for the same period in 2014. Loss from operations was $25,515,000 compared to $20,947,000 a year ago. Net loss was $25,691,000, or $1.01 per basic and diluted share compared to a net loss of $21,231,000 or $0.99 per basic and diluted share for the same period in 2014. The company reiterated its 2015 annual revenue guidance of $48 million to $53 million.

Veracyte, Inc. to Report Q3, 2015 Results on Nov 05, 2015

Veracyte, Inc. announced that they will report Q3, 2015 results at 5:15 PM, US Eastern Standard Time on Nov 05, 2015

Similar Private Companies By Industry

Company Name Region
ELENZA, Inc. United States
V.S.M. Investors, LLC United States
The Egg Factory, LLC United States
Life-Tech, Inc. United States
Avantis Medical Systems, Inc. United States

Recent Private Companies Transactions

Private Placement
April 22, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Veracyte, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at